The constituent stocks MacroGenics closed down 14.75%, Scholar Rock, Morphic Holding, Novavax Pharmaceuticals (NVAX), and Travere Therapeutics fell 12.78%-9.42%; while MyGN (MYGN) closed up 2.76%, Wave Life Sciences, Erasca, Nurix, and Autolus Therapeutic

The constituent stocks MacroGenics closed down 14.75%, Scholar Rock, Morphic Holding, Novavax Pharmaceuticals (NVAX), and Travere Therapeutics fell 12.78%-9.42%; while MyGN (MYGN) closed up 2.76%, Wave Life Sciences, Erasca, Nurix, and Autolus Therapeutics rose 6.10%-7.86%.

Zhitong Finance04:58

Wells Fargo Starts Wave Life Sciences at Buy, Cites Valuation

Seeking AlphaMay 16 02:11

WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on WAVE Life Sciences (NASDAQ:WVE) in the last three months.The table below summarizes their recent

BenzingaMay 15 21:01

Wave Life Sciences Initiated at Overweight by Wells Fargo

Wave Life Sciences Initiated at Overweight by Wells Fargo

Dow JonesMay 15 20:29

WAVE Life Sciences (WVE.US) was first covered by Wells Fargo, giving it an increase in holdings rating, with a target price of $11.00.

WAVE Life Sciences (WVE.US) was first covered by Wells Fargo, giving it an increase in holdings rating, with a target price of $11.00.

Zhitong FinanceMay 15 20:21

WAVE Life Sciences Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 88.36% Wells Fargo → $11 Initiates Coverage On → Overweight 04/01/2024 191.1% Truist Securities

BenzingaMay 15 20:17